184 related articles for article (PubMed ID: 30769179)
21. Electrochemical analysis of uric acid excretion to the intestinal lumen: Effect of serum uric acid-lowering drugs and 5/6 nephrectomy on intestinal uric acid levels.
Fujita K; Yamada H; Iijima M; Ichida K
PLoS One; 2019; 14(12):e0226918. PubMed ID: 31891613
[TBL] [Abstract][Full Text] [Related]
22. High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a.
Moriyama T; Itabashi M; Takei T; Kataoka H; Sato M; Shimizu A; Iwabuchi Y; Nishida M; Uchida K; Nitta K
J Nephrol; 2015 Aug; 28(4):451-6. PubMed ID: 25355499
[TBL] [Abstract][Full Text] [Related]
23. [URATE AS A POTENTIAL RISK FACTOR OF CARDIOVASCULAR AND RENAL DISEASES].
Butković M
Acta Med Croatica; 2016 Dec; 70(4-5):233-9. PubMed ID: 29087102
[TBL] [Abstract][Full Text] [Related]
24. Intensive uric acid-lowering therapy in CKD patients: the protocol for a randomized controlled trial.
Kasahara M; Kuwabara Y; Moriyama T; Tanabe K; Satoh-Asahara N; Katsuya T; Hiramitsu S; Shimada H; Sato T; Saito Y; Nakagawa T
Clin Exp Nephrol; 2020 Mar; 24(3):235-241. PubMed ID: 31729647
[TBL] [Abstract][Full Text] [Related]
25. The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD.
Sato Y; Feig DI; Stack AG; Kang DH; Lanaspa MA; Ejaz AA; Sánchez-Lozada LG; Kuwabara M; Borghi C; Johnson RJ
Nat Rev Nephrol; 2019 Dec; 15(12):767-775. PubMed ID: 31296965
[TBL] [Abstract][Full Text] [Related]
26. Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis.
Kanji T; Gandhi M; Clase CM; Yang R
BMC Nephrol; 2015 Apr; 16():58. PubMed ID: 25928556
[TBL] [Abstract][Full Text] [Related]
27. Impact of Hyper- and Hypo-Uricemia on Kidney Function.
Miake J; Hisatome I; Tomita K; Isoyama T; Sugihara S; Kuwabara M; Ogino K; Ninomiya H
Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238929
[TBL] [Abstract][Full Text] [Related]
28. Serum uric acid and the risk of cardiovascular and renal disease.
Borghi C; Rosei EA; Bardin T; Dawson J; Dominiczak A; Kielstein JT; Manolis AJ; Perez-Ruiz F; Mancia G
J Hypertens; 2015 Sep; 33(9):1729-41; discussion 1741. PubMed ID: 26136207
[TBL] [Abstract][Full Text] [Related]
29. Uric acid metabolism of kidney and intestine in a rat model of chronic kidney disease.
Nagura M; Tamura Y; Kumagai T; Hosoyamada M; Uchida S
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):550-558. PubMed ID: 27906625
[TBL] [Abstract][Full Text] [Related]
30. Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan.
Wang S; Shu Z; Tao Q; Yu C; Zhan S; Li L
Nephrology (Carlton); 2011 Nov; 16(8):767-76. PubMed ID: 21854506
[TBL] [Abstract][Full Text] [Related]
31. Uricase-deficient rats with similarly stable serum uric acid to human's are sensitive model animals for studying hyperuricemia.
Gao Y; Yu Y; Qin W; Fan N; Qi Y; Chen H; Duan W
PLoS One; 2022; 17(3):e0264696. PubMed ID: 35239728
[TBL] [Abstract][Full Text] [Related]
32. Potential Probiotic
Lee Y; Werlinger P; Suh JW; Cheng J
Microorganisms; 2022 Apr; 10(5):. PubMed ID: 35630296
[TBL] [Abstract][Full Text] [Related]
33. A natural complex product Yaocha reduces uric acid level in a live zebrafish model.
Xiong XY; Liang J; Guo SY; Dai MZ; Zhou JL; Zhang Y; Liu Y
J Pharmacol Toxicol Methods; 2020; 102():106681. PubMed ID: 32087362
[TBL] [Abstract][Full Text] [Related]
34. Oral Treatment With an Engineered Uricase, ALLN-346, Reduces Hyperuricemia, and Uricosuria in Urate Oxidase-Deficient Mice.
Pierzynowska K; Deshpande A; Mosiichuk N; Terkeltaub R; Szczurek P; Salido E; Pierzynowski S; Grujic D
Front Med (Lausanne); 2020; 7():569215. PubMed ID: 33330529
[TBL] [Abstract][Full Text] [Related]
35. GLUT9 as a potential drug target for chronic kidney disease: Drug target validation by a Mendelian randomization study.
Ueda M; Fukui K; Kamatani N; Kamitsuji S; Matsuo A; Sasase T; Nishiu J; Matsushita M
J Hum Genet; 2023 Oct; 68(10):699-704. PubMed ID: 37308567
[TBL] [Abstract][Full Text] [Related]
36. Clinical Effects of Topiroxostat on Renal and Endothelial Function in A Patient with Chronic Kidney Disease and Hyperuricemic Arteriolopathy: A Case Report.
Tanaka A; Nakamura T; Sato E; Node K
Drugs R D; 2017 Mar; 17(1):97-101. PubMed ID: 28074335
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoids Increase Renal Excretion of Urate in Mice by Downregulating Urate Transporter 1.
Li G; Han L; Ma R; Saeed K; Xiong H; Klaassen CD; Lu Y; Zhang Y
Drug Metab Dispos; 2019 Nov; 47(11):1343-1351. PubMed ID: 31519697
[TBL] [Abstract][Full Text] [Related]
38. Novel drug discovery strategies for gout.
Richette P; Garay R
Expert Opin Drug Discov; 2013 Feb; 8(2):183-9. PubMed ID: 23231400
[TBL] [Abstract][Full Text] [Related]
39. Green tea polyphenols decreases uric acid level through xanthine oxidase and renal urate transporters in hyperuricemic mice.
Chen G; Tan ML; Li KK; Leung PC; Ko CH
J Ethnopharmacol; 2015 Dec; 175():14-20. PubMed ID: 26344851
[TBL] [Abstract][Full Text] [Related]
40. [Gout: an overview of available urate lowering therapies].
Richette P
Ann Pharm Fr; 2012 May; 70(3):133-8. PubMed ID: 22655581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
